| CXSL2300042 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2023-01-17 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSL2101131 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-06-11 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CYSB2300230 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2023-12-09 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CYSB2200110 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2022-04-27 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSB2200007 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2022-01-21 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CYSB2400335 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2025-01-01 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSB2200104 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2022-12-10 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSL2101060 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-05-11 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSL2300534 | 替雷利珠单抗注射液（皮下注射） | tislelizumab | Injection | Biological Products(2.1) | New Drug Application | 2023-08-02 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd | | | view |
| CYSB2101060 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-05-21 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSL2101005 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-03-18 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CYSB2400093 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2024-04-19 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSL2200060 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2022-01-29 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSL2101123 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-06-08 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2300125 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-11-09 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSS2101021 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-08-20 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2200049 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2022-06-08 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CYSB2400327 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2024-12-14 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSL2200599 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2022-12-10 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSL2200566 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2022-11-09 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
